Delcath stock falls out of compliance with Nasdaq – The Business Review (Albany)
|
Delcath stock falls out of compliance with Nasdaq
The Business Review (Albany) Stock in the Queensbury, NY-based medical device manufacturer has been trading below $ 1 a share, the minimum price required for a Nasdaq listing, since April 30. That was the day the U.S. Food and Drug Adminstration said Delcath may have to conduct … Delcath Systems, Inc. (NASDAQ:DCTH) Long Term Investor Alert: Investigation … |
